Conference
LBA37 IMMUTACE: A biomarker-orientated, multi center phase II AIO study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC)
Authors
Vogel A; Saborowski A; Hinrichs J; Ettrich TJ; Ehmer U; Martens UM; Mekolli A; De Toni E; Berg T; Geißler M
Volume
32
Publisher
Elsevier
Publication Date
September 1, 2021
DOI
10.1016/j.annonc.2021.08.2114
Conference proceedings
Annals of Oncology
ISSN
0923-7534